US-India Healthcare Summit: New Business Models Needed To Reach the World's Poor
This article was originally published in The Pink Sheet Daily
The "bottom of the pyramid" represents a huge opportunity for Western companies, but they need to overcome hurdles to maximize the potential - and to fend off competitors emerging from around the world.
You may also be interested in...
NEW DELHI - Pfizer has further expanded its generic drug portfolio by signing two more license and supply agreements with Strides Arcolab, just four months after Pfizer partnered with the Bangalore-based drug manufacturer to bring generic injectable and oral drugs to the U.S. market
The acquisition of Solvay's pharmaceutical unit, completed in February, gave Abbott a substantial branded generics business and strengthened its international presence. Now the company is looking to build on those assets with an enhanced emerging market strategy
Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis - If Lawyers Could Get Out Of The Way
CAMBRIDGE, Mass. - Greater R&D collaboration was the theme of the day at the star-studded U.S.-India Chamber of Commerce biopharma and healthcare summit